Literature DB >> 21798470

Assessment of cardiovascular risk in primary care patients in France.

Eric Bruckert1, Geneviève Bonnelye, Florence Thomas-Delecourt, Lucas André, Pierre-Henri Delaage.   

Abstract

BACKGROUND: Current guidelines for the prevention of cardiovascular disease emphasize the importance of assessing global cardiovascular risk, but there is evidence that risk is often assessed inaccurately. AIMS: To compare general practitioner-reported global cardiovascular risk in French primary care patients with estimates based on established risk-scoring systems, and to identify factors accounting for any mismatch between the analyses.
METHODS: Data on patients, aged 50 years or older, seen during two 3-day periods were provided by 619 general practitioners. Physicians rated each patient's cardiovascular risk as low, moderate or high, according to their perception; in addition, risk was assessed using the Framingham and Systematic coronary risk evaluation (SCORE) risk-scoring systems.
RESULTS: A total of 13,446 patients aged greater or equal to 50 years were included. Of 11,241 patients with no previous history of cardiovascular disease, 47% were considered by their physicians to be at low risk of cardiovascular disease and 14% to be at high risk. In that population, 72% of patients rated as high risk according to the Framingham system and 77% rated as high risk according to SCORE system were incorrectly assessed by their physicians; similar results were observed in patient cohorts based on whether or not patients had received treatment for dyslipidaemia. Weighted kappa analysis showed poor agreement between physician risk assessment and both the Framingham and SCORE risk-scoring systems.
CONCLUSION: This study underlines the mismatch between GP-estimated cardiovascular risk and the risk assessed using scoring systems, especially for high-risk patients.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798470     DOI: 10.1016/j.acvd.2011.04.007

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  2 in total

1.  Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases.

Authors:  Ronan Roussel; Christophe Chaignot; Alain Weill; Florence Travert; Boris Hansel; Michel Marre; Philippe Ricordeau; François Alla; Hubert Allemand
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

2.  Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation-The POWER Survey.

Authors:  Guy De Backer; Robert J Petrella; Assen R Goudev; Ghazi Ahmad Radaideh; Andrzej Rynkiewicz; Atul Pathak
Journal:  Int J Hypertens       Date:  2013-07-25       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.